These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 19790155

  • 1. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.
    Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR.
    Liver Transpl; 2009 Oct; 15(10):1270-7. PubMed ID: 19790155
    [Abstract] [Full Text] [Related]

  • 2. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics.
    Earl TM, Cooil B, Rubin JE, Chari RS.
    Transplantation; 2008 Jul 27; 86(2):238-44. PubMed ID: 18645485
    [Abstract] [Full Text] [Related]

  • 3. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Velidedeoglu E, Chapman WC, Markmann JF.
    Transplantation; 2004 Jan 15; 77(1):99-106. PubMed ID: 14724442
    [Abstract] [Full Text] [Related]

  • 4. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
    Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ.
    Liver Transpl; 2008 Aug 15; 14(8):1100-6. PubMed ID: 18668666
    [Abstract] [Full Text] [Related]

  • 5. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 6. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J, Downey KK, Akoad M, Cacciarelli TV.
    Liver Transpl; 2007 Nov 15; 13(11):1564-9. PubMed ID: 17969210
    [Abstract] [Full Text] [Related]

  • 7. Hospitalization patterns before and after liver transplantation.
    Schaubel DE, Wei G, Dykstra DM, Port FK, Merion RM.
    Transplantation; 2007 Dec 27; 84(12):1590-4. PubMed ID: 18165769
    [Abstract] [Full Text] [Related]

  • 8. Split-liver transplantation in the high-MELD adult patient: are we being too cautious?
    Nadalin S, Schaffer R, Fruehauf N.
    Transpl Int; 2009 Jul 27; 22(7):702-6. PubMed ID: 19254241
    [Abstract] [Full Text] [Related]

  • 9. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation.
    Akyildiz M, Karasu Z, Arikan C, Kilic M, Zeytunlu M, Gunsar F, Ersoz G, Akarca U, Batur Y, Tokat Y.
    Transplant Proc; 2004 Jun 27; 36(5):1442-4. PubMed ID: 15251354
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.
    Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF.
    Liver Transpl; 2006 May 27; 12(5):754-61. PubMed ID: 16528716
    [Abstract] [Full Text] [Related]

  • 12. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.
    Liver Transpl; 2011 Jun 27; 17(6):674-84. PubMed ID: 21618688
    [Abstract] [Full Text] [Related]

  • 13. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR, Al-Freah MA, Portal AJ, Sizer E, Bernal W, Auzinger G, Rela M, Wendon JA, Heaton ND, O'Grady JG, Heneghan MA.
    Liver Transpl; 2010 May 27; 16(5):668-77. PubMed ID: 20440776
    [Abstract] [Full Text] [Related]

  • 14. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM.
    Aliment Pharmacol Ther; 2005 Jan 15; 21(2):169-77. PubMed ID: 15679767
    [Abstract] [Full Text] [Related]

  • 15. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.
    Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783
    [Abstract] [Full Text] [Related]

  • 16. [Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].
    Feng X, Wei YG, Li FQ, Yuan D, Jiang H, Du ZG, Yin J, Li B.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 27; 39(5):801-4. PubMed ID: 19024318
    [Abstract] [Full Text] [Related]

  • 17. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR, Lee TC, Udell IW, O'mahoney CA, Karpen SJ, Carter BA, Goss JA.
    Liver Transpl; 2006 Mar 27; 12(3):475-80. PubMed ID: 16498644
    [Abstract] [Full Text] [Related]

  • 18. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?
    Maluf DG, Edwards EB, Kauffman HM.
    Transplantation; 2006 Dec 27; 82(12):1653-7. PubMed ID: 17198254
    [Abstract] [Full Text] [Related]

  • 19. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 27; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 20. Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score.
    Åberg F, Mäklin S, Räsänen P, Roine RP, Sintonen H, Koivusalo AM, Höckerstedt K, Isoniemi H.
    Liver Transpl; 2011 Nov 27; 17(11):1333-43. PubMed ID: 21770017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.